Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products

August 6th, 2026 | 11:21 AM BUSINESS Healthcare & Pharmaceuticals 1

Facebook Twitter Google+ LinkedIn Pinterest
By Padraic Halpin

Nutrition supplement maker Glanbia (GL9.I) hiked its ‌full-year profit forecast on Thursday following bumper demand for its protein products, including from customers using them in tandem with weight-loss drugs.

Related Posts

© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT